Latest debt-to-equity ratio
Akari Therapeutics Debt-to-equity ratio
Direct answer
Akari Therapeutics's debt-to-equity ratio is 3.73%.
The verified market snapshot reports 3.73%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 27, 2026.
Get free Akari Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 3.73%
Explore related company data
View Akari Therapeutics's market capitalizationView Akari Therapeutics's price-to-book ratioView Akari Therapeutics's return on equityView Akari Therapeutics's dividend yieldView Akari Therapeutics's 52-week price rangeView Akari Therapeutics's profit marginView all Akari Therapeutics key metricsReturn to Akari Therapeutics profile